Manufacturer record
Azot Life Sciences: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Azot Life Sciences (Himachal Pradesh) were declared Not of Standard Quality between April 2025 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: AT-2139A, Lansoprazole Orally Disintegrating Tablets 15mg (exp Sep 2027). Drug Testing Laboratory, Madurai-19 (state lab) found it not of standard quality: content - Lansoprazole. Listed in the September 2026 alert.
Records by type
5 records linked to Azot Life Sciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Lansoprazole Orally Disintegrating Tablets 15mg | Batch AT-2139AMfg Oct 2025 · Exp Sep 2027 | content - LansoprazoleOther | Drug Testing Laboratory, Madurai-19State lab | Sep 2026 |
| Itraconazole Capsules IP | Batch AC-662HMfg Nov 2025 · Exp Oct 2027 | The sample does not conform to I.P. with respect to test for Dissolution.Dissolution | CDL, KolkataCDSCO lab | Aug 2026 |
| Pantoprazole Gastro-resistant Tablets IP | Batch AT-1952AMfg Jun 2025 · Exp May 2027 | Content of Pantoprazole (84.7%)Other | Drugs Testing Laboratory, Madurai-19State lab | Jul 2026 |
| Aceclofenac & Paracetamol Tablets IP (Bioace-P Tablets) | Batch AT-1872AMfg Apr 2025 · Exp Mar 2027 | The Sample Received Does Not Conform To I.P. Addendum 2024 Specification With Respect To The Test For Dissolutions For Aceclofenac And Paracetamol Only.Dissolution | CDTL, HyderabadCDSCO lab | Oct 2025 |
| Burmoxicla+V(Amoxycill in & Potassium Clavulanate Oral Suspension IP) | Batch ABD-187CMfg Jun 2024 · Exp Nov 2025 | Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate oral suspension with Clavulanic Acid in Potassium Clavulanate respect to the content ofOther | DTL MaduraiState lab | Apr 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.